Viewing Study NCT01953692

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-02-20 @ 6:46 PM
Study NCT ID: NCT01953692
Status: COMPLETED
Last Update Posted: 2021-08-04
First Post: 2013-09-26
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
Sponsor: Merck Sharp & Dohme LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Multiple Myeloma View
None Hodgkin Lymphoma View
None Non-Hodgkin Lymphoma View
None Diffuse Large B-Cell Lymphoma View
None Follicular Lymphoma View
None Primary Mediastinal B-Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PD1 View
None PD-1 View
None PDL1 View
None PD-L1 View